Oregon Health Sciences University researchers study benefits of treatments offered within hours of a stroke

November 29, 1999

Portland, Ore. -- Researchers from the Oregon Stroke Center at Oregon Health Sciences University have always known that battling a stroke is a race against time. Now, two independent studies conducted through the Oregon Stroke Center Hospital Network show medical response time can dictate which treatment may offer the most promising outcome for a patient. Both studies will be printed in the Dec. 1 edition of The Journal of the American Medical Association.

The first study involves a drug known simply as t-PA, often considered the first line of defense by doctors. The drug is used to combat strokes caused by blood clots in the brain. It works to dissolve the clot, clearing the blockage. The drug has proved to improve stroke recovery if it is administered within three hours of a stroke. However, it was not known if t-PA also would work if given after three hours, until now.

Researchers used t-PA to treat more than 600 stroke patients at sites across North America, including 71 patients in Oregon. Patients were given either the drug or a placebo within three to five hours of having their stroke. In patients treated after three hours, researchers noted no benefit in terms of improved recovery when the patients were tested at three months; however, the drug did increase the chance of serious cranial bleeding. These results demonstrate that t-PA should not be used after three hours.

The second study, also to be published in the Dec. 1 issue of JAMA, offers hope for patients who are unable to get treatment within three hours of a stroke. In this situation, another form of therapy has shown promise. This treatment involves the direct application of a clot-busting drug called ProUrokinase to the blocked artery using a catheter. The procedure is called an angiogram. Once again, health centers across North America were involved in the trial, including OHSU and Portland Veterans Affairs Medical Center.

In this study, doctors were limited to treating patients with a blockage in the middle cerebral artery, which is the major artery to the brain. The treatment was offered to those who had suffered a large stroke within the previous six hours. Despite the physical limits of working with a catheter, this therapy offered doctors a longer window of opportunity for treating patients. Three months following the initial treatment, doctors witnessed an excellent recovery for 40 percent of the patients treated with ProUrokinase, compared to only 25 percent of untreated patients. However, unlike t-PA, which can be given at any hospital, this catheter treatment is only available at a few specialized stroke centers.

Wayne Clark, M.D., associate professor of neurology and director of the Oregon Stroke Center at OHSU, says both studies provide doctors with information needed to make critical decisions following a stroke. "It is hoped that the findings of these two studies will help doctors decide which type of stroke therapy is best for the patient," said Clark. "This research accompanied by the emergence of promising new treatments, should help increase the chances that stroke patients undergo a complete recovery."

The Oregon Stroke Center is recognized as a national leader in research and patient care. The center is home to a mobile stroke team available 24 hours a day to treat patients at five Portland-area hospitals in the critical early stages of a stroke. Providence St. Vincent Hospital, Providence Portland Hospital, Legacy Emanuel Hospital, Portland VA Medical Center and OHSU are partners on the stroke team.
-end-


Oregon Health & Science University

Related Stroke Articles from Brightsurf:

Stroke alarm clock may streamline and accelerate time-sensitive acute stroke care
An interactive, digital alarm clock may speed emergency stroke care, starting at hospital arrival and through each step of the time-sensitive treatment process.

Stroke patients with COVID-19 have increased inflammation, stroke severity and death
Stroke patients who also have COVID-19 showed increased systemic inflammation, a more serious stroke severity and a much higher rate of death, compared to stroke patients who did not have COVID-19, according a retrospective, observational, cross-sectional study of 60 ischemic stroke patients admitted to UAB Hospital between late March and early May 2020.

'Time is vision' after a stroke
University of Rochester researchers studied stroke patients who experienced vision loss and found that the patients retained some visual abilities immediately after the stroke but these abilities diminished gradually and eventually disappeared permanently after approximately six months.

More stroke awareness, better eating habits may help reduce stroke risk for young adult African-Americans
Young African-Americans are experiencing higher rates of stroke because of health conditions such as high blood pressure, diabetes and obesity, yet their perception of their stroke risk is low.

How to help patients recover after a stroke
The existing approach to brain stimulation for rehabilitation after a stroke does not take into account the diversity of lesions and the individual characteristics of patients' brains.

Kids with headache after stroke might be at risk for another stroke
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.

High stroke impact in low- and middle-income countries examined at 11th World Stroke Congress
Less wealthy countries struggle to meet greater need with far fewer resources.

Marijuana use might lead to higher risk of stroke, World Stroke Congress to be told
A five-year study of hospital statistics from the United States shows that the incidence of stroke has risen steadily among marijuana users even though the overall rate of stroke remained constant over the same period.

We need to talk about sexuality after stroke
Stroke survivors and their partners are not adequately supported to deal with changes to their relationships, self-identity, gender roles and intimacy following stroke, according to new research from the University of Sydney.

Standardized stroke protocol can ensure ELVO stroke patients are treated within 60 minutes
A new study shows that developing a standardized stroke protocol of having neurointerventional teams meet suspected emergent large vessel occlusion (ELVO) stroke patients upon their arrival at the hospital achieves a median door-to-recanalization time of less than 60 minutes.

Read More: Stroke News and Stroke Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.